Bacterial Infection Segment, by Clinical Indication is Largest Market Share Holder of The Mediterranean Fish Vaccine Market during 2022–2030

According to our new research study on " Mediterranean Fish Vaccine Market Forecast to 2030 – COVID-19 Impact and Regional Analysis – by Vaccine Type, Route of Administration, Species, and Clinical Indication." The Mediterranean fish vaccine market size is expected to grow from grow from US$ 96,323.46 million in 2022 to US$ 2,09,030.80 million by 2030; it is estimated to register a CAGR of 10.2% from 2022 to 2030. The major key driving factors for the market growth are government initiatives to develop the Mediterranean aquaculture industry and the surging demand for aquatic animal-derived food products. On the other hand, strict regulatory policies for the approval of vaccines hinder the Mediterranean fish vaccine market growth.

Development of Novel Vaccines Provides Growth Opportunities for The Growth of Mediterranean Fish Vaccine Market. 

Various disease outbreaks caused by bacteria, viruses, and parasites have decelerated the progress of the global aquaculture industry for several decades. Besides harming human health, emerging diseases also dramatically affect aquatic animals. Vaccination is a well-known, effective prophylactic measure employed to manage this problem. However, traditional vaccines still have several drawbacks and limitations, which has driven the focus of researchers to novel vaccines such as chimeric multiepitope vaccines. Based on the current understanding of genomics and immunoproteomics, and the presently available bioinformatics tools, researchers can now identify the potential targeted epitopes that are recognized by immune cells. Further, Fish Species with a as the cost of techniques such as whole genome sequencing continues to decline, it opens the way for species-specific vaccine development. These factors are likely to encourage the Mediterranean fish vaccine market players to invest in developing new vaccines against viral, parasitic, or bacterial infectious diseases for which vaccines are presently unavailable.

Mediterranean Fish Vaccine Market, by Clinical Indication, 2022 (%) 

Source: Business Market Insights Analysis

Further, the development of effective mucosal vaccines and optimization of their administration process are expected to accelerate novel vaccine development, in turn, encouraging aquaculture businesses in Mediterranean countries to regularize fish vaccination processes. The effective use of emergency (autogenous) vaccines is anticipated to help handle emerging disease challenges and create immense opportunities for the market players to grow.

Based on clinical indication, the market is into bacterial infection and viral infection. The bacterial infection segment held the largest Mediterranean fish vaccine market share in 2022 and is anticipated to register the highest CAGR during the forecast period. Bacteria are responsible for many fatal diseases in fishes like furunculosis, columnaris, fin and tail rot, vibriosis, dropsy, cotton mouth disease and tuberculosis. Several bacterial infections in fish species, including Aeromonas septicemia, Edwardsiellosis, Columnaris, Streptococcosis, and vibriosis have been reported in the aquaculture sector.

Bacterial Pathogens of Fishes –

USDA Approved Bacterial Fish Vaccines –

Based on the region, the Mediterranean fish market is classified into France, Italy, Spain, Greece, Egypt, Turkey, Israel, and the rest of Mediterranean fish market. France is the largest and fastest growing country followed by Italy and Spain in the Mediterranean fish vaccine market.

Zoetis Inc, Merck & Co Inc, HIPRA SA, ICTYODEV SAS, Acuipharma Aquaculture Health SL, Phibro Animal Health Corp, Vaxxinova International BV, Kyoto Biken Laboratories Inc, Elanco Animal Health Inc, and Ceva SA. are among the key fish vaccine companies operating in the Mediterranean fish vaccine market.

These operating operation companies in the Mediterranean fish vaccine market adopt various organic and inorganic strategies. Organic strategies mainly include product launches and product approvals. Acquisitions, collaborations, and partnerships are among the inorganic growth strategies witnessed in the Mediterranean fish vaccine market. These growth strategies allow the market players to expand their businesses and enhance their geographic presence, thereby contributing to the overall Mediterranean fish vaccine market growth. Further, acquisition and partnership strategies help them strengthen their customer base and expand their product portfolios.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com